Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population

This study has been completed.
Sponsor:
Collaborators:
Prevemed-Medibo
Medical Laboratory CRI
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00365911
First received: August 17, 2006
Last updated: June 1, 2011
Last verified: June 2011

August 17, 2006
June 1, 2011
March 2006
December 2009   (final data collection date for primary outcome measure)
A possible association between renal clearance and found cardiovascular risk factors and risk factors by exposition to toxic substantia during work. [ Time Frame: At time T0 ] [ Designated as safety issue: No ]
A possible association between renal clearance and found cardiovascular risk factors and risk factors by exposition to toxic substantia during work.
Complete list of historical versions of study NCT00365911 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population
Prevalence of Renal Failure and Risk Factors in an Unreferred Healthy Population

Blood sample is taken for measurement of serum creatinine, cystatin C, clone V haemoglobin, cholesterol, urine acid, glycemia and CRP.

The medical file is gathered. There will be searched for an association between renal function and cardiovascular risk factors and risk factors by exposition to toxic substantia during work.

Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Healthy
Procedure: Taking blood sample
A blood sample will be taken.
Not Provided
van der Tol A, Van Biesen W, Verbeke F, De Groote G, Vermeiren F, Eeckhaut K, Vanholder R. Towards a rational screening strategy for albuminuria: results from the unreferred renal insufficiency trial. PLoS One. 2010 Oct 13;5(10):e13328.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
2000
December 2009
December 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • 20-55 years
  • Male and female subjects
Both
20 Years to 65 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Belgium
 
NCT00365911
2006/038
No
Arjan Van Der Tol, University Hospital Ghent
University Hospital, Ghent
  • Prevemed-Medibo
  • Medical Laboratory CRI
Principal Investigator: Raymond Vanholder, MD, PhD University Hospital, Ghent
Principal Investigator: Wim Van Biesen, MD, PhD University Hospital, Ghent
University Hospital, Ghent
June 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP